Artificial Intelligence-Based Electrocardiographic Analysis Facilitated Diagnosis of Hypertrophic Cardiomyopathy With Successful Treatment Using Mavacamten
The case describes the use of AI-ECG to diagnose HCM appropriately in a 61-year-old symptomatic patient with no previous knowledge of the disease. Following an appropriate diagnosis of HCM, the patient was initiated on the novel cardiac myosin inhibitor mavacamten, with an excellent clinical response.
Authors
- Milind Y. Desai (ORCID: https://orcid.org/0000-0003-0010-9797)
- Katy Rutkowski
- Susan Ospina (ORCID: https://orcid.org/0009-0004-7175-6582)
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1016/j.jaccas.2024.103228
- Citations
- 1
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.39